These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Antigen : Human TAFI
Application : Western Blot (TAFI only), ELISA, inhibits TAFI activation Host : Mouse Immunogen : purified human TAFI
The Safety Data Sheets and Notices are accessible to our registered customers.
TAFI is an enzyme that stabilizes the clot by protecting the fibrin from the clot from lysis. TAFI is activated by thrombin and its activation is amplified in the presence of thrombomodulin. Activated TAFI removes the C-terminal lysine and arginine residues of fibrin which are necessary for the binding of t-PA, plasmin and plasminogen to fibrin.
The vast majority of antibodies is pure (without additives) with > 95 % purity SDS-PAGE. Stock antidobies are supplied in 50 % glycerol/water (v/v) for ease of storage and use. Both small, laboratory scale and bulk, production scale quantities are available. Expiration date of one year from delivery.
Custom needs by supplying you conjugated with biotin, HRP, FITC or other conjugates. Special formulations are available upon request. Discount according to quantities